Oral medications may feel easier to obtain, easier to hide, and easier to misuse
We present innovative solutions, including the Alina pen injector platform and Aidaptus auto-injector platform, that cater to the specific needs of GLP-1 therapies, offering customization, streamlined manufacturing, and compatibility with various drug formulations
GLP-1, GIP, glucagon, amylin, and PYY exert pleiotropic actions across multiple organ systems involved in energy homeostasis
It is a testament to our commitment to providing high-quality, personalized healthcare solutions
Results show that DSIP-CBBBP effectively restores neurotransmitter balance and improves sleep more significantly than delta sleep peptide alone, highlighting its potential for sleep-related therapies
This work creates a significant opportunity to improve patient outcomes while reducing unnecessary treatment costs by identifying which patients are most likely to respond to GLP-1 therapies